Cargando…
Immunotherapeutic Approaches for Treating Hepatocellular Carcinoma
SIMPLE SUMMARY: The incidence of liver cancer is increasing worldwide. When detected early, the most common form of primary liver cancer (hepatocellular carcinoma, or HCC) can be treated with surgery and organ transplantation (when feasible). However, in most cases, HCC is detected at advanced stage...
Autores principales: | Shen, Wanying, Chen, Yujie, Lei, Pan, Sheldon, Marisela, Sun, Yutong, Yao, Fan, Ma, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599666/ https://www.ncbi.nlm.nih.gov/pubmed/36291797 http://dx.doi.org/10.3390/cancers14205013 |
Ejemplares similares
-
Immunotherapeutic approaches for hepatocellular carcinoma
por: Longo, Vito, et al.
Publicado: (2017) -
Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance
por: Lei, Pan, et al.
Publicado: (2023) -
Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular Carcinoma
por: Devan, Aswathy R., et al.
Publicado: (2021) -
Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches
por: Mantovani, Stefania, et al.
Publicado: (2020) -
From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
por: Fu, Yaojie, et al.
Publicado: (2019)